BIO.NRW COVID-19 Information and Contact Platform
At this point BIO.NRW offers all companies and scientists in NRW a platform with actual informations in connection with the COVID-19 pandemic. This includes support programs and funding from the state, the federal government and the EU as well as relevant news from companies and science.
In addition, we also offer you the possibility of individual cooperation and contact requests: If you have offers for your (product) development regarding COVID-19 in the fields of diagnostics, therapy, prevention, clinical studies or in a broader sense to medical technology solutions and/or are looking for partners, please feel free to contact us via email at bio.nrw@bio.nrw.de.
We will publish your offers and/or requests in this area. In case you do not wish to publish your information, you are nevertheless welcome to contact the office so that we can support you while maintaining confidentiality.
Click here for the contact form.
Corona platform of the EU with information on funding opportunities related with Covid-19
Weiterlesen …
Overview of COVID-19 associated (and general) funding, financing, information
Weiterlesen …
COVID-19 News
Coronavirus: Commission mobilises €123 million for research and innovation to combat the threat of variants
The Commission is mobilising €123 million from Horizon Europe, the new EU research and innovation programme, for urgent research into...
Vaccines: Commission hosts first EU matchmaking event to mobilise Europe’s full potentialfor the production of COVID-19 vaccines
Today, the Commission is hosting the first pan-European matchmaking event with over 300participating companies from 25 Member States to...
Covid-19: EMA recommends conditional approval for Janssen vaccine
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended that the single-dose...
European Commission authorises fourth vaccine against COVID-19
Press release March 11 Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine...
Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE
New consortium of research institutions will coordinate vaccine trials in the European Union / The long-term goal is to strategically...
EU-Commission establishs HERA Incubator
EU-Commission has proposed an European bio-defence preparedness plan against COVID-19 variants, the so called “HERA Incubator”. With...
Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine
Establishment of additional lipid production in Germany for use with mRNA-based vaccines Expansion of leading positionas integrated...
Positive interim phase 1/2a data on Janssen’s COVID19 vaccine candidate.
The New England Journal of Medicine (NEJM) has published interim phase 1/2a data for Janssen’s Covid19 vaccine candidate. They show that the vaccine ca...
DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2
Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike...
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
Bayer to support CureVac in numerous areas, including development and supply of CVnCoV, they plan to facilitate the supply of several hundred million doses.<...
Phase II Clinical Trial of the COVID-19 Vaccine of Janssen Authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has approved the Phase II clinical trial of the SARS-CoV-2...
QIAGEN to launch rapid portable test that can detect active infections of SARS-CoV-2 in less than 15 min
Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, is easy to use and provides accurate results in less than 15 minutes…
...Events
„Das Mikrobiom als individuelle Signatur des Menschen und seine klinische Relevanz“
Weiterlesen …
SAVE THE DATE – Künstliche Intelligenz in der roten Biotechnologie
Weiterlesen …
BIO.NRW.eco ist dabei: Die Greener Manufacturing Show 2021 in Köln
Weiterlesen …
BIO-EUROPE Spring 2021
Weiterlesen …
Driving Change – How Green Chemistry and Digitalisation lead the way to a Sustainable Economy
Weiterlesen …
10th BIO.NRW Business Angel Congress
Weiterlesen …
Horizont Europa – Was bietet das neue Forschungsrahmenprogramm der EU für Fördermöglichkeiten in den Bereichen Gesundheit, Bioökonomie und Umwelt
Weiterlesen …
Our Databases
Database of Biotech Companies
in North-Rhine Westphalia
BIO.NRW offers you a free of charge, well-structured and comprehensive database of Life science and biotechnology companies in North-Rhine Westphalia. The information includes company profiles with contact details, a summary of products, services, and technologies.
Academic Database
in North-Rhine Westphalia
This database is the first of its kind in Germany and aims to facilitate the cooperation between science and industry. The database is updated constantly.
Media
publications and presentations
BIO.NRW offers you information about the science and business location of North-Rhine Westphalia. Besides you can find information about financing, subsidies and other exciting topics of the biotechnology and bioeconomy field.
Contact
Address
Geschäftsstelle BIO.NRW
Merowingerplatz 1
D-40225 Düsseldorf
Please feel free to contact us
Data Protection Notice
You can revoke the personal data collected and processed by you within the scope of this form for the purpose of fulfilling your request at any time. The legality of the processing based on your consent remains unaffected until receipt of your revocation. You can find more detailed information in our privacy policy.
Mit dem Laden der Karte akzeptieren Sie die Datenschutzerklärung von Google.
Mehr erfahren
